3 Cannabis Stocks to Buy Ahead of 2020

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) and two other cannabis companies are the ones you want in your cannabis portfolio ahead of 2020.

| More on:

It’s been almost a year since legalization in Canada, and what a year it’s been.

After a summer in 2018 that saw cannabis companies hit record-setting numbers, those numbers have plummeted to sometimes more than half the share price seen last year. Many have since found it difficult to reach anything close to those share prices since that time, and it has left many investors wondering if the cannabis bubble has indeed burst.

While I believe that bubble may not have burst, it certainly is floating away, especially when it comes to the opportunities investors are seeing right now. Last year, investors could buy pretty much any cannabis stock and expect it to do well. Now, you have to be a bit more picky. And that’s a good thing.

With the one-year anniversary of legalization nearing, and the legalization of edibles by the end of the year, it’s time to think about what cannabis companies are the ones investors should be focusing on before we countdown to 2020.

Canopy Growth

Canopy Growth (TSX:WEED)(NYSE:CGC) has been getting a lot of flack ahead of its earnings report on Aug. 14. While the company has made a substantial number of announcements, those announcements haven’t amounted to much when it comes to the company’s bottom line.

Analyst are expecting some growth from the company with sales up 17% from the same time last year. The same cannot be said for revenue, with analysts expecting a decline of 75%, which would put it below some of its peers’ recent reports. But while the company has spent a lot to grow rapidly, it has also set itself up for long-term gains. Production is being amped up, and production costs are being cut down. With edibles on the line, Canopy stands to make significant gains through its partnerships. This should significantly add to the company’s sales growth as earnings come in for 2020.

Aurora

Next up, we have another top performer of the cannabis industry with Aurora Cannabis (TSX:ACB)(NYSE:ACB). Aurora has also had its fair share of criticism, especially for not having a brand-name partnership that many (if not all) of its peers have already picked up. This has caused the company to dilute shares to keep up its pace of expansion.

But all that doubt seems like it could be changing, as Aurora predicts its next quarter to hit revenues of up to $107 million — a 460% increase from the year before. It’s also picked up production, expecting to sell the upper end of 25,000 to 30,000 kilograms in its fourth quarter.

Just like Canopy, Aurora is setting itself up for long-term gains, and those gains should start producing in 2020, as the company has more and more of its 15 separate production facilities come online. Right now, the company can produce 150,000 kilograms per year, but by June of next year, that should hit a whopping 625,000 kilograms, if not more. Once Canada’s needs are met, Aurora will then go global, and that’s when some serious cash could come in.

Curaleaf

Finally, we have a relatively newcomer to the market with Curaleaf Holding (CSE:CURA). While other marijuana producers were on a downward spiral last fall, Curaleaf spiked in late October by 4,300% after its initial public offering, debuting with a market cap of $4.5 billion! Year to date, that growth has continued by 42%. So, what’s going on with this newbie?

The main point: it has a strong American presence. The company has an enormous presence already, expanding into the CBD market as well, and should legalization happen, Curaleaf will be there to pick up even more cash. Beyond its current presence, Curaleaf is also seeking the heavyweight title of largest cannabis company in the world after acquiring Grassroots Companies and a pending acquisition of Select, the leading cannabis wholesale brand in the United States. When these acquisitions go through, it should be 2020, so that’s around when investors should see a significant increase in share price.

Foolish takeaway

All three of these cannabis companies are down now, but it won’t be for long. In fact, while 2020 looks like a solid time to see immense increases, all three of these companies are setting themselves up for long-term production. If you’re looking for growth, look no further than Canopy, Aurora, and Curaleaf.

Fool contributor Amy Legate-Wolfe owns shares of Aurora Cannabis and Canopy Growth.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »